Horizons ETFs Management ( Canada ) Inc. (” Horizons ETFs “) has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF (” HMMJ “:TSX) and the Horizons US Marijuana Index ETF (” HMUS “:NEO).

HMMJ is the world’s first ETF offering direct exposure to North American-listed securities that have significant business activities in the marijuana industry. This quarter, seven constituents were removed from HMMJ’s portfolio:


Deletions

Company Name

Ticker

Exchange

Agraflora Organics International Inc.

AGRA

CSE

Supreme Cannabis Co.

FIRE

TSX

Khiron Life Sciences Corp.

KHRN

TSX-V

Namaste Technologies Inc.

N-X

TSX-V

Pharmacielo Ltd.

PCLO

TSX-V

Sundial Growers Inc.

SNDL

NASDAQ

WeedMD Inc.

WMD

TSX-V

HMMJ is an index (or passively managed) ETF, which seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. This index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry. The North American Marijuana Index selects from a current universe of companies that have operations that may include one or more offerings of biopharmaceuticals, medical manufacturing, distribution, bio-products and other ancillary businesses related to the marijuana industry. Securities within HMMJ’s index generally have a market capitalization of greater than C$75 million .

Despite a strong recovery in Q2 2020  following the market volatility in March, Canada’s marijuana industry struggled in the third quarter in the face of COVID-19’s continued pressure on businesses and a lack of positive news to buoy the sector, said Steve Hawkins , President and CEO of Horizons ETFs. ” Additionally, growing confidence in potentially increasing federal political support for U.S.-based multi-state operators (MSOs) has resulted in net new money in the sector being increasingly allocated to U.S. names rather than the Canadian licensed producers.”

Rebalancing of the North American Marijuana Index, and consequently HMMJ, occurs each calendar quarter. At that point, all stocks eligible for inclusion in the index are generally re-weighted by their respective market capitalization.

The holdings of HMMJ and its current portfolio weights are regularly updated and available at https://www.HorizonsETFs.com/HMMJ . It is important to note that HMMJ may not hold all of the constituent names in its index. The manager of the HMMJ, through the use of a stratified sampling strategy, may invest in securities that closely match the investment characteristics of HMMJ’s index, provided they are consistent with the ETF’s investment objectives and strategies.

Performance Update as at September 30, 2020 *

1
Month

3
Month

6
Month

YTD

1
Year

3
Year

Annualized Since
Inception**

HMMJ

-12.74%

-13.57%

-0.09%

-28.42%

-45.73%

-8.28%

-8.26%

Source: Bloomberg, as at September 30, 2020 . **Since HMMJ’s inception on April 4, 2017 .

The indicated rates of return are the historical annual compounded total returns, including changes in unit value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. The ETF is not guaranteed, its value changes frequently, and past performance may not be repeated.

HMUS REBALANCE

HMUS is the world’s first U.S.-focused marijuana index ETF. HMUS seeks to replicate, to the extent possible, the performance of the US Marijuana Companies Index, net of expenses. This index is designed to provide exposure to the performance of a basket of publicly listed companies having significant business activities in, or significant exposure to, the marijuana or hemp industries in the United States . Constituents of this index are selected from Canadian and U.S. exchanges. While some securities may be listed on major North American exchanges, the majority of the securities currently trade on North American exchanges that include but are not limited to the Canadian Securities Exchange and the Aequitas NEO Exchange.

This rebalance resulted in four additions and three removals from the portfolio:

Additions

Company Name

Ticker

Exchange

4Front Ventures Corp.

FFNT

CSE

ICanic Brands Company Inc.

ICAN

CSE

Red White & Bloom Brands Inc.

RWB

CSE

Tuscan Holdings Corp.

THCAU

NASDAQ

Deletions

Company Name

Ticker

Exchange

Flower One Holdings Inc.

FONE

CSE

iAnthus Capital Holdings Inc.

IAN

CSE

Slang Worldwide Inc.

SLNG

CSE

“The outlook for the U.S. cannabis industry has surged with the increasing possibility of a Democrat victory in November, particularly following Vice Presidential candidate Kamala Harris’ recent statements in support of decriminalization and legalization,” said Mr. Hawkins. “Despite continued federal restrictions on their businesses, U.S. MSOs have continued to scale-up and strengthen their brands and could be well-poised to challenge Canada’s LPs at home and on a global level once critical legislation permits them.”

Rebalancing of the US Marijuana Companies Index, and consequently HMUS, occurs each calendar quarter. At that point, all stocks eligible for inclusion in the index are generally re-weighted by their respective market capitalization.

The holdings of HMUS and its current portfolio weights are regularly updated and available at https://www.HorizonsETFs.com/HMUS . It is important to note that HMUS may not hold all of the constituent names in its index. The manager of HMUS, through the use of a stratified sampling strategy, may invest in securities that closely match the investment characteristics of HMUS’ index, provided they are consistent with the ETF’s investment objectives and strategies.

Performance Update as at September 30, 2020 *

1
Month

3
Month

6
Month

YTD

1
Year

Annualized Since
Inception**

HMUS

-13.81%

17.66%

45.66%

-15.17%

-22.60%

-47.88%

Source: Bloomberg, as at September 30, 2020 . **Since HMUS’ inception on April 17, 2019 .

The indicated rates of return are the historical annual compounded total returns, including changes in unit value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. The ETFs is not guaranteed, its value changes frequently, and past performance may not be repeated.

About Horizons ETFs Management ( Canada ) Inc. ( www.HorizonsETFs.com )

Horizons ETFs Management ( Canada ) Inc. is an innovative financial services company and offers one of the largest suites of exchange traded funds in Canada . The Horizons ETFs product family includes a broadly diversified range of solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Horizons ETFs has over $14.4 billion of assets under management and 93 ETFs listed on major Canadian stock exchanges.

Certain statements may constitute a forward-looking statement, including those identified by the expression “expect” and similar expressions (including grammatical variations thereof). The forward-looking statements are not historical facts but reflect the author’s current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking statements. These forward-looking statements are made as of the date hereof and the authors do not undertake to update any forward-looking statement that is contained herein, whether as a result of new information, future events or otherwise,

Commissions, management fees and expenses all may be associated with an investment in Horizons US Marijuana Index ETF and the Horizons Marijuana Life Sciences Index ETF  (the “ETFs”) managed by Horizons ETFs Management ( Canada ) Inc. The ETFs are not guaranteed, their values change frequently and past performance may not be repeated. The prospectus contains important detailed information about the ETFs. Please read the prospectus before investing.

There are risks associated with this product. HMUS is expected to invest in the Marijuana industry in certain U.S. states that have legalized marijuana for therapeutic or adult-use, which is currently illegal under U.S. federal law. HMUS will passively invest in companies involved in the marijuana industry in the U.S. where local state law regulates and permits such activities, as well as in companies involved in the Canadian legal Marijuana industry. HMUS will not be directly engaged in the manufacture, importation, possession, use, sale or distribution of marijuana in either Canada or the U.S. Please read the full risk disclosure in the prospectus before investing.

SOURCE Horizons ETFs Management ( Canada ) Inc.

News Provided by Canada Newswire via QuoteMedia

Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the appointment of Dr. Joel Moody, MD, MPH, DTM&H, as a medical and clinical advisor to the Company to assist in the expansion of clinical studies in Canada and the clinical data analysis on the ongoing U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.

“We would like to welcome Dr. Moody as a medical and clinical advisor to our team and we look forward to his contributions in our ongoing FDA Phase 3 clinical study as well as expanding our COVID-19 studies in Canada,” said Michael Frank, CEO of Revive. “Dr. Moody’s experience in clinical epidemiology, data analysis and research are key to our FDA Phase 3 study as we gather clinical data from patients enrolled.”

Keep reading... Show less

– FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF), based in Vancouver, BC today announced that Andriyko Herchak, CEO, will present live at VirtualInvestorConferences.com on December 3 rd .

Keep reading... Show less

First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support patients with posttraumatic stress disorder

Keep reading... Show less

Multi-year partnership designates BioSteel as new official sports drink of Philadelphia 76ers team, Training Complex, and the presenting partner of 76ers Training Camp

BioSteel today announced a multi-year deal with the Philadelphia 76ers, making the sports hydration company the official sports drink of the team. BioSteel will also serve as a partner of the Philadelphia 76ers Training Complex, and the presenting partner for 76ers Training Camp, which begins next week.

Keep reading... Show less

Achievements with Scalability and Compatibility Pave Way for Next Phase of Advancement

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is excited to announce that the Company’s holding, Arcology, a cluster-computing powered AI blockchain ecosystem with unlimited scalability, has updated its working roadmap in response to its Testnet 1.0 results

Keep reading... Show less